{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:13:53Z","timestamp":1784837633310,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"\u201cFundaci\u00f3n para el Desarrollo de la Oncolog\u00eda (FUNDESO)\u201d","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12967-017-1162-3","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T06:35:19Z","timestamp":1489991719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7295-6074","authenticated-orcid":false,"given":"Miguel F.","family":"Sanmamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Uriol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Capelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Muriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Berros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pardo-Coto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Alvarez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Jim\u00e9nez Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Astudillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"key":"1162_CR1","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374\u2013403.","journal-title":"Eur J Cancer."},{"key":"1162_CR2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(82)90710-3","volume":"2","author":"MJ Peckham","year":"1982","unstructured":"Peckham MJ, Barrett A, Husband JE, Hendry WF. Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet. 1982;2:678\u201380.","journal-title":"Lancet"},{"key":"1162_CR3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(87)90889-0","volume":"2","author":"LS Freedman","year":"1987","unstructured":"Freedman LS, Parkinson MC, Jones WG, Oliver RT, Peckham MJ, Read G, et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet. 1987;2:294\u20138.","journal-title":"Lancet"},{"key":"1162_CR4","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1200\/JCO.1992.10.11.1762","volume":"10","author":"G Read","year":"1992","unstructured":"Read G, Stenning SP, Cullen MH, Parkinson MC, Horwich A, Kaye SB, et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol. 1992;10:1762\u20138.","journal-title":"J Clin Oncol."},{"key":"1162_CR5","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1200\/JCO.2007.12.0899","volume":"26","author":"P Albers","year":"2008","unstructured":"Albers P, Siener R, Krege S, Schmelz H-U, Dieckmann K-P, Heidenreich A, et al. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01\/94. J Clin Oncol. 2008;26:2966\u201372.","journal-title":"J Clin Oncol"},{"key":"1162_CR6","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","volume":"20","author":"P Warde","year":"2002","unstructured":"Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol. 2002;20:4448\u201352.","journal-title":"J Clin Oncol"},{"key":"1162_CR7","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1200\/JCO.2005.01.9810","volume":"23","author":"J Aparicio","year":"2005","unstructured":"Aparicio J, Germ\u00e0 JR, del Muro XG, Maroto P, Arranz JA, S\u00e1enz A, et al. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol. 2005;23:8717\u201323.","journal-title":"J Clin Oncol"},{"key":"1162_CR8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.2010.30.1044","volume":"29","author":"T Tandstad","year":"2011","unstructured":"Tandstad T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A, et al. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group. J Clin Oncol. 2011;29:719\u201325.","journal-title":"J Clin Oncol"},{"key":"1162_CR9","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2003.07.169","volume":"21","author":"P Albers","year":"2003","unstructured":"Albers P, Siener R, Kliesch S, Weissbach L, Krege S, Sparwasser C, et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol. 2003;21:1505\u201312.","journal-title":"J Clin Oncol"},{"key":"1162_CR10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/bjc.1995.387","volume":"72","author":"RA Huddart","year":"1995","unstructured":"Huddart RA, Wooster R, Horwich A, Cooper CS. Microsatellite instability in human testicular germ cell tumours. Br J Cancer. 1995;72:642\u20135.","journal-title":"Br J Cancer"},{"key":"1162_CR11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/molehr\/7.12.1099","volume":"7","author":"M Devouassoux-Shisheboran","year":"2001","unstructured":"Devouassoux-Shisheboran M, Mauduit C, Bouvier R, Berger F, Bouras M, Droz JP, et al. Expression of hMLH1 and hMSH2 and assessment of microsatellite instability in testicular and mediastinal germ cell tumours. Mol Hum Reprod. 2001;7:1099\u2013105.","journal-title":"Mol Hum Reprod"},{"key":"1162_CR12","first-page":"2758","volume":"62","author":"F Mayer","year":"2002","unstructured":"Mayer F, Gillis AJM, Dinjens W, Oosterhuis JW, Bokemeyer C, Looijenga LHJ. Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment. Cancer Res. 2002;62:2758\u201360.","journal-title":"Cancer Res"},{"key":"1162_CR13","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/ijc.23291","volume":"122","author":"A Velasco","year":"2008","unstructured":"Velasco A, Corvalan A, Wistuba II, Riquelme E, Chuaqui R, Majerson A, et al. Mismatch repair expression in testicular cancer predicts recurrence and survival. Int J Cancer. 2008;122:1774\u20137.","journal-title":"Int J Cancer"},{"key":"1162_CR14","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1200\/JCO.2008.18.8623","volume":"27","author":"F Honecker","year":"2009","unstructured":"Honecker F, Wermann H, Mayer F, Gillis AJM, Stoop H, van Gurp RJLM, et al. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. J Clin Oncol. 2009;27:2129\u201336.","journal-title":"J Clin Oncol"},{"key":"1162_CR15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrc2088","volume":"7","author":"SV Sharma","year":"2007","unstructured":"Sharma SV, Bell DW, Settleman J, Haber DA. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer. 2007;7:169\u201381.","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 4","key":"1162_CR16","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","volume":"37","author":"RI Nicholson","year":"2001","unstructured":"Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer. 2001;37(Suppl 4):S9\u201315.","journal-title":"Eur J Cancer."},{"key":"1162_CR17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJMra044389","volume":"353","author":"DS Krause","year":"2005","unstructured":"Krause DS, Van Etten RA. Tyrosine kinases as targets for cancer therapy. N Engl J Med. 2005;353:172\u201387.","journal-title":"N Engl J Med"},{"key":"1162_CR18","first-page":"2770","volume":"7","author":"M Moroni","year":"2001","unstructured":"Moroni M, Veronese S, Schiavo R, Carminati O, Sorensen BS, Gambacorta M, et al. Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors. Clin Cancer Res. 2001;7:2770\u20135.","journal-title":"Clin Cancer Res"},{"key":"1162_CR19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/cncr.10671","volume":"95","author":"C Kollmannsberger","year":"2002","unstructured":"Kollmannsberger C, Mayer F, Pressler H, Koch S, Kanz L, Oosterhuis JW, et al. Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer. Cancer. 2002;95:301\u20138.","journal-title":"Cancer"},{"key":"1162_CR20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00428-003-0835-x","volume":"443","author":"L Hechelhammer","year":"2003","unstructured":"Hechelhammer L, St\u00f6rkel S, Odermatt B, Heitz PU, Jochum W. Epidermal growth factor receptor is a marker for syncytiotrophoblastic cells in testicular germ cell tumors. Virchows Arch. 2003;443:28\u201331.","journal-title":"Virchows Arch"},{"key":"1162_CR21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/annonc\/mdg244","volume":"14","author":"A Madani","year":"2003","unstructured":"Madani A, Kemmer K, Sweeney C, Corless C, Ulbright T, Heinrich M, et al. Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors. Ann Oncol. 2003;14:873\u201380.","journal-title":"Ann Oncol."},{"key":"1162_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/modpathol.2008.133","volume":"22","author":"X Wang","year":"2009","unstructured":"Wang X, Zhang S, Maclennan GT, Biermann K, Foster RS, Beck SD, et al. Epidermal growth factor receptor protein expression and gene amplification in the chemorefractory metastatic embryonal carcinoma. Mod Pathol. 2009;22:7\u201312.","journal-title":"Mod Pathol."},{"key":"1162_CR23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12094-010-0532-6","volume":"12","author":"I Dur\u00e1n","year":"2010","unstructured":"Dur\u00e1n I, Garc\u00eda-Velasco A, Ballest\u00edn C, Garc\u00eda E, Mart\u00ednez-Tello F, Pond GR, et al. Expression of EGFR, HER-2\/neu and KIT in germ cell tumours. Clin Transl Oncol. 2010;12:443\u20139.","journal-title":"Clin Transl Oncol."},{"key":"1162_CR24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJMoa050736","volume":"353","author":"M-S Tsao","year":"2005","unstructured":"Tsao M-S, Sakurada A, Cutz J-C, Zhu C-Q, Kamel-Reid S, Squire J, et al. Erlotinib in lung cancer\u2014molecular and clinical predictors of outcome. N Engl J Med. 2005;353:133\u201344.","journal-title":"N Engl J Med"},{"key":"1162_CR25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1471-2407-11-172","volume":"11","author":"I Centeno","year":"2011","unstructured":"Centeno I, Blay P, Santamar\u00eda I, Astudillo A, Pitiot AS, Osorio FG, et al. Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma. BMC Cancer. 2011;11:172.","journal-title":"BMC Cancer"},{"key":"1162_CR26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","volume":"96","author":"A Umar","year":"2004","unstructured":"Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, R\u00fcschoff J, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"1162_CR27","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/cncr.29190","volume":"121","author":"L Moreira","year":"2015","unstructured":"Moreira L, Mu\u00f1oz J, Cuatrecasas M, Quintanilla I, Leoz ML, Carballal S, et al. Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer. Cancer. 2015;121:1395\u2013404.","journal-title":"Cancer"},{"key":"1162_CR28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47:207\u201314.","journal-title":"Cancer"},{"key":"1162_CR29","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1200\/JCO.2006.07.9434","volume":"24","author":"R Wit de","year":"2006","unstructured":"de Wit R, Fizazi K. Controversies in the management of clinical stage I testis cancer. J Clin Oncol. 2006;24:5482\u201392.","journal-title":"J Clin Oncol"},{"key":"1162_CR30","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/annonc\/mds579","volume":"24","author":"J Beyer","year":"2013","unstructured":"Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, et al. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol. 2013;24:878\u201388.","journal-title":"Ann Oncol"},{"key":"1162_CR31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1200\/JCO.1986.4.7.1031","volume":"4","author":"P Hoskin","year":"1986","unstructured":"Hoskin P, Dilly S, Easton D, Horwich A, Hendry W, Peckham MJ. Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J Clin Oncol. 1986;4:1031\u20136.","journal-title":"J Clin Oncol"},{"key":"1162_CR32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4161\/cbt.3.10.1135","volume":"3","author":"A Velasco","year":"2004","unstructured":"Velasco A, Riquelme E, Schultz M, Wistuba II, Villarroel L, Pizarro J, et al. Mismatch repair gene expression and genetic instability in testicular germ cell tumor. Cancer Biol Ther. 2004;3:977\u201382.","journal-title":"Cancer Biol Ther"},{"key":"1162_CR33","first-page":"4319","volume":"25","author":"J Olasz","year":"2005","unstructured":"Olasz J, M\u00e1ndoky L, G\u00e9czi L, Bodrogi I, Csuka O, Bak M. Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors. Anticancer Res. 2005;25:4319\u201324.","journal-title":"Anticancer Res"},{"key":"1162_CR34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-4598-1-8","volume":"1","author":"S Koul","year":"2002","unstructured":"Koul S, Houldsworth J, Mansukhani MM, Donadio A, McKiernan JM, Reuter VE, et al. Characteristic promoter hypermethylation signatures in male germ cell tumors. Mol Cancer. 2002;1:8.","journal-title":"Mol Cancer"},{"key":"1162_CR35","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","volume":"21","author":"FR Hirsch","year":"2003","unstructured":"Hirsch FR, Varella-Garcia M, Bunn PAJ, Di Maria MV, Veve R, Bremmes RM, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol. 2003;21:3798\u2013807.","journal-title":"J Clin Oncol"},{"key":"1162_CR36","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1111\/j.1349-7006.2010.01638.x","volume":"101","author":"K Miyai","year":"2010","unstructured":"Miyai K, Yamamoto S, Asano T, Tamai S, Matsubara O, Tsuda H. Protein overexpression and gene amplification of epidermal growth factor receptor in adult testicular germ cell tumors: potential role in tumor progression. Cancer Sci. 2010;101:1970\u20136.","journal-title":"Cancer Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-017-1162-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T09:00:47Z","timestamp":1498381247000},"score":1,"resource":{"primary":{"URL":"http:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-017-1162-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1162"],"URL":"https:\/\/doi.org\/10.1186\/s12967-017-1162-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,20]]},"article-number":"62"}}